The U.S. doesn’t have an official job code for clinical research professionals. David Vulcano explains why that gap is holding back the workforce.
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
ON-DEMAND WEBINARS
Watch to learn the reasons why research sites, site networks, health systems, academic medical centers, and cancer centers use a CTMS to centralize information related to protocols, subjects, staff, financials and billing, and much more.
During this presentation, industry experts provide insights on how clinical trial stakeholders can enrich the participants' journeys in harmony with PFDD objectives.
Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.
Watch this presentation and demonstration of One Home for Sites for the latest updates on how the industry is coming together — even competitors — to alleviate the technology burden on research sites.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1257716223 fda guide]( "Key Takeaways From The Recent FDA DCT Draft Guidance")
Key Takeaways From The Recent FDA DCT Draft GuidanceGet an overview of draft perspectives and key points to reinforce decentralized clinical trial training, oversight, and risk assessment to guarantee a study's integrity, patient safety, and success.
-
![GettyImages-1480239219 data platform]( "Clinical Trial Insights: Integrating Direct Data Capture With EDC")
Clinical Trial Insights: Integrating Direct Data Capture With EDCBy capturing data directly from the source, discover how researchers access insights faster and make more informed decisions.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![COVID 19 Coronavirus Mask Wearer]( "Our Unified Platform Serves As eSource For COVID Treatment Trial")
Our Unified Platform Serves As eSource For COVID Treatment TrialSignant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.
-
![GettyImages-1302453801 trial design ps]( "What Universalized Terminology Means For Decentralized Research")
What Universalized Terminology Means For Decentralized ResearchMany DCT stakeholders have attempted to release terminology guides as it relates to their own dealings, however, there had never been a wide range of universalized DCT terms until now.
-
![agenic-ai-GettyImages-2245878087]( "Agentic AI Is Transforming Life Sciences Discovery And Operations")
Agentic AI Is Transforming Life Sciences Discovery And Operations73% of pharma companies are planning or deploying agentic AI. Discover who’s leading and how intelligent agents are transforming R&D.
-
![GettyImages-1489414892 Technological Software Engineering Department Manager Using A Laptop]( "Five Ways Site-Facing Technology Helps Sponsors And CROs")
Five Ways Site-Facing Technology Helps Sponsors And CROsSite-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.
-
![domino effect and risk management concept iStock-1272805554]( "eCOA Risk Management In The Digital Age")
eCOA Risk Management In The Digital AgeRegulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.
-
![AI Intelligence]( "Realizing The Potential Of AI And Machine Learning In Clinical Research")
Realizing The Potential Of AI And Machine Learning In Clinical ResearchThe life sciences industry has not yet scaled or realized the full potential of AI/ML. Here are four real-world use cases that can encourage researchers to unlock new efficiencies and insights in their studies.
-
![supply chain management, pharma business logistics-GettyImages-960991960]( "What Is Interactive Response Technology (IRT)?")
What Is Interactive Response Technology (IRT)?Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
RECENT NEWSLETTERS
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
